This is likely explained by the notion that the deregulated HDAC axis which operates in breast carcinoma cells is not otherwise present in normal cells, hence attempting to relieve these repressive circuitries through HDAC blockade has no effect on PPARγ expression in non-cancerous cells. Here, HDAC9 is linked to breast carcinoma.